End-of-day quote
Shenzhen S.E.
23:00:00 16/07/2024 BST
5-day change
1st Jan Change
63.61
CNY
+3.38%
+3.94%
-22.80%
Sino Biological,Inc.'s Equity Buyback announced on February 23, 2024, has closed with 3,029,368 shares, representing 2.36% for CNY 199.85 million.
The company closed its plan on July 12, 2024.
Tranche Update on Sino Biological,Inc.'s Equity Buyback Plan announced on February 23, 2024.
07-15
CI
Sino Biological,Inc.'s Equity Buyback announced on February 23, 2024, has closed with 3,029,368 shares, representing 2.36% for CNY 199.85 million.
07-11
CI
Tranche Update on Sino Biological,Inc.'s Equity Buyback Plan announced on February 23, 2024.
07-02
CI
InDevR, Inc. and Sino Biological,Inc. Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene Therapy
06-05
CI
Sino Biological,Inc. Approves Cash Dividend for the Year 2023
05-15
CI
Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
04-28
CI
Sino Biological,Inc. completed the acquisition of SignalChem Biotech Inc. from Signalchem Lifesciences Corporation.
04-25
CI
Sino Biological,Inc. Proposes Final Cash Dividend for the Year 2023
04-23
CI
Sino Biological,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
04-23
CI
Tranche Update on Sino Biological,Inc.'s Equity Buyback Plan announced on February 23, 2024.
04-02
CI
Sino Biological,Inc. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 19, 2024.
02-22
CI
Bio-Link Pharmaceutical Technology Co., Ltd. announced that it has received funding from Cathay Capital Private Equity SAS, Sino Biological,Inc., Suzhou GSL Venture Capital Management Company, Beijing GSR United Capital Management Consulting Co., Ltd., Tianjin Qianxi Investment Management Partnership Ent. (L.P.), Shanghai Pudong Haiwang Private Fund Management Co., Ltd. and other investors
02-20
CI
Sino Biological,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
24/10/23
CI
Sino Biological to Acquire Canada’s SignalChem Biotech for $48 Million
23/10/23
MT
Sino Biological,Inc. entered into Share Purchase Agreement to acquire SignalChem Biotech Inc. from Signalchem Lifesciences Corporation for CAD 65.85 million.
19/10/23
CI
Sino Biological,Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
27/08/23
CI
Certain A Shares of Sino Biological Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2023.
16/08/23
CI
Sino Biological Unit to Lease Beijing Property to Shenzhou Cell Engineering
26/05/23
MT
Sino Biological Buys Land for 918 Million Yuan
23/05/23
MT
Sino Biological,Inc Approves the Final Cash Dividend for the Year 2022, Payable on 24 May 2023
16/05/23
CI
Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
25/04/23
CI
Sino Biological,Inc. Proposes Final Cash Dividend for the Year 2022
24/04/23
CI
Sino Biological,Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
21/04/23
CI
Sino Biological,Inc. Approves Board Elections
23/03/23
CI
PhaBuilder announced that it has received $53.4 million in funding from Sino Biological,Inc., Beijing Zhonghai Investment Management Co., Ltd., Shanghai Free Trade Zone Equity Fund Management Co., Ltd., Chengtong Fund Management Co., Ltd., CNPC Kunlun Capital Co., Ltd., Shanghai Lingang Innovation Center Co., Ltd.
01/02/23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Sino Biological Inc is a China-based biotechnology company engaged in the research and development, production, sales and technical services of biological reagents. The Company's main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services. The Company operates in the domestic market and overseas markets.
More about the company
Last Close Price
63.61
CNY
Average target price
96
CNY
Spread / Average Target
+50.92%
Consensus
1st Jan change
Capi.
-22.80% 1.06B +24.74% 47.96B -0.47% 42.45B +43.96% 41.47B +25.40% 31.6B +17.96% 28.63B -4.47% 28.03B +50.73% 14.56B +42.56% 14.14B +1.46% 12.58B
Other Biotechnology & Medical Research
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1